de Bono, J. S., Concin, N., Hong, D. S., Thistlethwaite, F. C., Machiels, J., Arkenau, H., . . . Lassen, U. (2019). Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): A first-in-human, multicentre, phase 1–2 trial. The lancet oncology, 20(3), 383-393. https://doi.org/10.1016/S1470-2045(18)30859-3
Citácia podle Chicago (17th ed.)de Bono, Johann S., et al. "Tisotumab Vedotin in Patients with Advanced or Metastatic Solid Tumours (InnovaTV 201): A First-in-human, Multicentre, Phase 1–2 Trial." The Lancet Oncology 20, no. 3 (2019): 383-393. https://doi.org/10.1016/S1470-2045(18)30859-3.
Citácia podľa MLA (8th ed.)de Bono, Johann S., et al. "Tisotumab Vedotin in Patients with Advanced or Metastatic Solid Tumours (InnovaTV 201): A First-in-human, Multicentre, Phase 1–2 Trial." The Lancet Oncology, vol. 20, no. 3, 2019, pp. 383-393, https://doi.org/10.1016/S1470-2045(18)30859-3.